Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4132 |  RNTX Rein Therapeutics, Inc. - Common Stock | 0.78 USD | -4.88% | 0.00% | -2.50% | -29.09% | 67.29 M USD | ||
| 4136 |  XBIT XBiotech Inc. - Common Stock | 2.29 USD | -0.43% | -0.87% | +0.88% | -28.88% | 69.82 M USD | ||
| 4143 |  CSBR Champions Oncology, Inc. - Common Stock | 5.14 USD | +3.63% | +1.78% | -15.74% | -29.01% | 71.41 M USD | ||
| 4144 |  MNOV MediciNova, Inc. - Common Stock | 1.47 USD | +5.00% | +12.21% | +13.08% | +9.70% | 72.36 M USD | ||
| 4152 |  CRDF Cardiff Oncology, Inc. - Common Stock | 1.01 USD | +14.77% | +8.60% | +20.24% | -56.47% | 78.57 M USD | ||
| 4153 |  BOLD Boundless Bio, Inc. - Common Stock | 3.00 USD | +3.45% | +5.26% | +16.73% | +158.62% | 68.24 M USD | ||
| 4165 |  HYFT MindWalk Holdings Corp. - Common Stock | 1.40 USD | -0.71% | 0.00% | 0.00% | -30.69% | 65.40 M USD | ||
| 4169 |  TENX Tenax Therapeutics, Inc. - Common Stock | 1.73 USD | -1.14% | -5.98% | -88.27% | -77.09% | 64.74 M USD | ||
| 4176 |  INMB INmune Bio Inc. - Common stock | 2.30 USD | -0.86% | +8.49% | +41.10% | -3.36% | 63.83 M USD | ||
| 4187 |  DOMH Dominari Holdings Inc. - Common Stock | 2.55 USD | -1.16% | -1.16% | -4.49% | -60.65% | 61.82 M USD | ||
| 4188 |  IMA ImageneBio, Inc. - Common Stock | 5.70 USD | +3.45% | -2.56% | +0.53% | -60.25% | 64.70 M USD | ||
| 4190 |  INKT MiNK Therapeutics, Inc. - Common Stock | 11.91 USD | -2.38% | +5.03% | +7.01% | +8.27% | 60.78 M USD | ||
| 4197 |  HRTX Heron Therapeutics, Inc. - Common Stock | 0.31 USD | -3.12% | -8.82% | -34.04% | -77.86% | 58.85 M USD | ||
| 4203 |  RNXT RenovoRx, Inc. - Common Stock | 1.33 USD | +0.76% | -6.34% | +47.78% | +41.49% | 60.02 M USD | ||
| 4217 |  IMMP Immutep Limited - American Depositary Shares | 0.38 USD | -2.56% | 0.00% | 0.00% | -78.16% | 55.49 M USD | ||
| 4220 |  NTRB Nutriband Inc. - Common Stock | 4.76 USD | +1.93% | +48.29% | +58.67% | -32.96% | 57.86 M USD | ||
| 4242 |  APLM Apollomics Inc. - Class A Ordinary Shares | 24.33 USD | +3.22% | +3.31% | +34.64% | +293.05% | 53.43 M USD | ||
| 4243 |  XLO Xilio Therapeutics, Inc. - Common Stock | 9.32 USD | +0.98% | +1.19% | +7.75% | +1231.43% | 53.89 M USD | ||
| 4255 |  TIL Instil Bio, Inc. - Common Stock | 7.62 USD | +2.56% | +2.97% | +6.72% | -60.90% | 51.68 M USD | ||
| 4270 |  TCRX TScan Therapeutics, Inc. - Common Stock | 0.77 USD | -1.28% | 0.00% | -4.94% | -59.47% | 48.90 M USD |
Nouvelles Biotechnology Stocks
Deutsche Bank dégrade argenx de Achat à Conserver en raison de la valorisation
Pourquoi l’action Monte Rosa Therapeutics chute-t-elle aujourd’hui ?
L’action Biomea Fusion bondit après la fin du recrutement pour son essai sur le diabète
L’action Monte Rosa chute au lancement d’une étude de phase 2 sur le cancer de la prostate
L’action Crinetics Pharmaceuticals atteint un record historique à 84,8 USD
H.C. Wainwright maintient sa recommandation sur Biomea Fusion après l’enrôlement
La FDA prolonge l’examen du deramiocel de Capricor au 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |